Compounds > gefitinib
Page last updated: 2024-09-03

gefitinib and Carcinoma, Ductal, Breast

gefitinib has been researched along with Carcinoma, Ductal, Breast in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, D; Hu, GN; Huang, BF; Li, X; Li, Y; Long, T; Su, CM; Tang, CH; Wang, CQ; Wang, Q; Wang, Y; Yuan, H; Zhao, YM1
Julka, PK; Mallick, S; Singh, A; Venkatesulu, BP1
Balslev, E; Bernsdorf, M; Ejlertsen, B; Ingvar, C; Jakobsen, EH; Jörgensen, L; Kimper-Karl, ML; Kroman, N; Saetersdal, A; Tuxen, MK1
Balslev, E; Bernsdorf, M; Ejlertsen, B; Grabau, D; Harder, E; Jakobsen, EH; Kroman, N; Lykkesfeldt, AE; von der Maase, H1
Hayes, DF1
Bundred, NJ; Chan, KC; Gandhi, A; Knox, WF; Potten, CS; Slamon, DJ1
Bundred, NJ; Chan, KC; Gee, JM; Knox, WF; Morris, J; Nicholson, RI; Potten, CS1

Trials

2 trial(s) available for gefitinib and Carcinoma, Ductal, Breast

ArticleYear
Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial.
    Breast cancer research and treatment, 2011, Volume: 126, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Double-Blind Method; Epirubicin; Female; Fever; Gefitinib; Humans; Leukopenia; Middle Aged; Neoadjuvant Therapy; Neutropenia; Quinazolines; Receptors, Estrogen; Research Design; Treatment Outcome; Tumor Burden

2011
Value of post-operative reassessment of estrogen receptor α expression following neoadjuvant chemotherapy with or without gefitinib for estrogen receptor negative breast cancer.
    Breast cancer research and treatment, 2011, Volume: 128, Issue:1

    Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; ErbB Receptors; Estrogen Receptor alpha; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Neoadjuvant Therapy; Phenotype; Quinazolines; Receptor, ErbB-2

2011

Other Studies

5 other study(ies) available for gefitinib and Carcinoma, Ductal, Breast

ArticleYear
EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.
    Scientific reports, 2017, Nov-15, Volume: 7, Issue:1

    Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Ductal, Breast; Carrier Proteins; Cell Movement; Cell Proliferation; ErbB Receptors; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Microfilament Proteins; Middle Aged; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Progression-Free Survival; Triple Negative Breast Neoplasms

2017
Non small cell carcinoma of lung with metachronous breast metastasis and cardiac tamponade: Unusual presentation of a common cancer.
    Journal of the Egyptian National Cancer Institute, 2015, Volume: 27, Issue:3

    Topics: Adult; Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Non-Small-Cell Lung; Cardiac Tamponade; Deoxycytidine; Female; Gefitinib; Gemcitabine; Humans; Lung Neoplasms; Neoplasms, Second Primary; Quinazolines; Radiography

2015
Tamoxifen: Dr. Jekyll and Mr. Hyde?
    Journal of the National Cancer Institute, 2004, Jun-16, Volume: 96, Issue:12

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Clinical Trials as Topic; Drug Resistance, Neoplasm; Enzyme Inhibitors; Epidermal Growth Factor; Female; Gefitinib; Humans; Neoplasms, Hormone-Dependent; Phosphorylation; Quinazolines; Receptor Cross-Talk; Receptor, ErbB-2; Receptors, Estrogen; Retrospective Studies; Selective Estrogen Receptor Modulators; Tamoxifen; Trastuzumab

2004
Blockade of growth factor receptors in ductal carcinoma in situ inhibits epithelial proliferation.
    The British journal of surgery, 2001, Volume: 88, Issue:3

    Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; ErbB Receptors; Female; Gefitinib; Humans; Immunohistochemistry; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Quinazolines; Receptor, ErbB-2; Transplantation, Heterologous; Trastuzumab; Tumor Cells, Cultured

2001
Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breast.
    Cancer research, 2002, Jan-01, Volume: 62, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cell Division; Down-Regulation; Enzyme Inhibitors; ErbB Receptors; Female; Gefitinib; Humans; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Precancerous Conditions; Quinazolines; Xenograft Model Antitumor Assays

2002